NCT00048113View on ClinicalTrials.gov

Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 10, 2001

Primary Completion Date

April 27, 2002

Study Completion Date

April 27, 2002

Conditions
Crohn's Disease
Interventions
DRUG

Alicaforsen

Trial Locations (30)

Unknown

Little Rock

Orange

San Diego

Arvada

Jacksonville

Winter Park

Chicago

Lexington

Louisville

Metairie

Baltimore

Chevy Chase

Detroit

Mexico

Lincoln

Buffalo

Rochester

Greensboro

Raleigh

Cincinnati

Cleveland

Hamilton

Oklahoma City

Portland

Tacoma

Madison

Milwaukee

Edmonton

Vancouver

Québec

Sponsors
All Listed Sponsors
lead

Ionis Pharmaceuticals, Inc.

INDUSTRY